CRF Inc. Introduces Enhanced Version of its Award-Winning e-PRO Technology; TrialMax(TM) 3.2 eDiary has been enhanced for ease of use and analysis of data in complex clinical trials
CRF Inc., the world leader in electronic Patient Reported Outcomes (ePRO) and wireless data collection solutions for the biopharmaceutical industry, has introduced TrialMax(TM) 3.2, the most complete study management tool, with the most advanced data management capabilities available in the ePRO market.
CRF’s TrialMax(TM) technology has enabled many clinical trial sponsors to collect primary and secondary efficacy data in shorter timescales and to conduct complex clinical trials with greater flexibility than any other ePRO solution. TrialMax(TM) 3.2 continues this tradition by incorporating functions that increase compliance, reliability and accuracy of data collected in global trials.
“Our TrialMax(TM) 3.2 eDiary design has exceeded even the industry’s expectations,” said Pekka Keskiivari, Chief Technology Officer of CRF Inc. “No other eDiary has software with the sensitivity needed to overcome the challenges of translating clinical trial programs into multiple languages, enabling trial sponsors to test their product over a broad spectrum of populations. We are proud that our constant innovation has led to improvements to our award-winning technology, which will enable our customers to stay ahead of the critical path.”
The 3.2 version includes a more robust data transport feature, which allows for easier sharing of questionnaires among eDiaries. It also has greater capability to function in 57 languages through the use of software that captures the nuances of colloquial usage and dialect, greatly improving the ease of use for patients and the quality of data collected for researchers. The advanced individual components provide the tools necessary to create intuitive eDiaries that guide the patient through the study procedures, facilitating high rates of compliance and resulting in high-quality data.
CRF Inc. pioneered the development of eDiaries and has since set the standard for industry experience and results. It was the first company to conduct wireless clinical trials, the first to adopt Clinical Data Interchange Standards Consortium (CDISC) worldwide technology standards, and it successfully managed the largest ever eDiary study in the industry.
About CRF Inc.
CRF Inc. is the leading global provider of electronic Patient Reported Outcomes (e-PRO) and wireless data collection solutions for the biopharmaceutical industry. Through innovative technology and a thorough understanding of drug development and mobile computing, the company is driving the change to safer and more efficient paper-free clinical trials. CRF Inc.’s technology has been used by more than 100,000 patients across 58 countries in 57 languages for 40 indications. The company has demonstrated the industry’s highest patient compliance rates — an average 95 percent compliance through Phase I, II, III and IV clinical trials — and unmatched patient and research site acceptance.
CRF Inc.’s award-winning product, TrialMax, is a flexible and customizable e-PRO technology that provides real-time patient monitoring, outstanding data accuracy and increased safety. Its unique features enable clinical trial sponsors to collect more valuable data faster and conduct complex clinical trials with greater flexibility than other e-PRO solutions. CRF Inc.’s experience combined with its dedication to ensuring the highest quality and most responsive customer service has made the company the biopharmaceutical industry’s most trusted partner.
For more information, please visit www.crfhealth.com .
